1
|
Xu XL, Lan JX, Huang H, Dai W, Peng XP, Liu SL, Chen WM, Huang LJ, Liu J, Li XJ, Zeng JL, Huang XH, Zhao GN, Hou W. Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents. Bioorg Med Chem 2023; 82:117234. [PMID: 36906964 DOI: 10.1016/j.bmc.2023.117234] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2023] [Revised: 02/27/2023] [Accepted: 03/02/2023] [Indexed: 03/09/2023]
Abstract
Cancer with low survival rates is the second main cause of death among all diseases in the world and consequently, effective antineoplastic agents are urgently needed. Allosecurinine is a plant-derived indolicidine securinega alkaloid shown bioactivity. The object of this study is to investigate synthetic allosecurinine derivatives with considerable anticancer capacity against nine human cancer cell lines as well as mechanism of action. We synthesized twenty-three novel allosecurinine derivatives and evaluated their antitumor activity against nine cancer cell lines for 72 h by MTT and CCK8 assays. FCM was applied to analyze the apoptosis, mitochondrial membrane potential, DNA content, ROS production, CD11b expression. Western blot was selected to analyze the protein expression. Structure-activity relationships were established and potential anticancer lead BA-3 which induced differentiation of leukemia cells towards granulocytosis at low concentration and apoptosis at high concentration was identified. Mechanism studies showed that mitochondrial pathway mediated apoptosis within cancer cells with cell cycle blocking was induced by BA-3. In addition, western blot assays revealed that BA-3 induced expression of the proapoptotic factor Bax, p21 and reduced the levels of antiapoptotic protein such as Bcl-2, XIAP, YAP1, PARP, STAT3, p-STAT3, and c-Myc. Collectively, BA-3 was a lead compound for oncotherapy at least in part, through the STAT3 pathway. These results were an important step in further studies on allosecurinine-based antitumor agent development.
Collapse
Affiliation(s)
- Xin-Liang Xu
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Jin-Xia Lan
- College of Public Health and Health Management, Gannan Medical University, Ganzhou 341000, PR China
| | - Hao Huang
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Wei Dai
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Xiao-Peng Peng
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Sheng-Lan Liu
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Wei-Ming Chen
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Le-Jun Huang
- College of Rehabilitation, Gannan Medical University, Ganzhou 341000, PR China
| | - Jun Liu
- College of Pharmacy, Jinan University, Guangzhou 510632, PR China
| | - Xiao-Jun Li
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Jun-Lin Zeng
- HuanKui Academy, Nanchang University, Nanchang 330006, PR China
| | - Xian-Hua Huang
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Guan-Nan Zhao
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Wen Hou
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China.
| |
Collapse
|
2
|
Hou W, Huang H, Wu XQ, Lan JX. Bioactivities and mechanism of action of securinega alkaloids derivatives reported prior to 2022. Biomed Pharmacother 2023; 158:114190. [PMID: 36916441 DOI: 10.1016/j.biopha.2022.114190] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 12/28/2022] [Accepted: 12/28/2022] [Indexed: 01/05/2023] Open
Abstract
Securinega alkaloids are indolizidine alkaloids extracted from the leaf and root of an Asian plant, Securinega suffruticosa. Since its discovery in 1956 by Russian scientists, numerous studies have been conducted on securinega alkaloids and their derivatives as bioactive agents. In this review, published work on the bioactivities and the mechanism of action of securinega alkaloids and their derivatives is addressed. References were obtained through for example, the Web of Science, Science Direct, Pubmed and Google Scholar. Research into the synthesis of securinega alkaloids and their derivatives lacking activity assessment has been excluded. Comprehensive reviews show that securinega alkaloids and their derivatives exhibit a wide range of activities among which antineoplastic activity and nervous system related activity were reported although the mechanisms of action remain in part unknown. The other activities such as induction of differentiation, reversal of multi-drug resistance, cardiovascular system related activity, anti-inflammatory, adjuvant agent and anti-pathogenic activity are also reviewed. We found that modification at the C12, C14, and C15 sites on securinine improves the antitumor activity, while derivatives in which a bivalent mimetic is linked to the C15 site is beneficial for differentiation induction activity and reversal of P-glycoprotein mediated drug resistance. The most related pathways involved in the bioactivity of securinega alkaloids and their derivatives are JAK/STAT, PI3K/AKT/mTOR and MAPK. A perspective and expectation concerning the research of securinega alkaloids is presented at the end of this article. This review indicates directions around which constant endeavor could be valuable for researchers in the near future.
Collapse
Affiliation(s)
- Wen Hou
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China.
| | - Hao Huang
- College of Pharmacy, Gannan Medical University, Ganzhou 341000, PR China
| | - Xue-Qiang Wu
- Center for Precision Medicine, Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou 514000, PR China
| | - Jin-Xia Lan
- College of Public Health and Health Management, Gannan Medical University, Ganzhou 341000, PR China.
| |
Collapse
|
3
|
Liu CJ, Fan XD, Jiang JG, Chen QX, Zhu W. Potential anticancer activities of securinine and its molecular targets. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2022; 106:154417. [PMID: 36063584 DOI: 10.1016/j.phymed.2022.154417] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/05/2021] [Revised: 08/12/2022] [Accepted: 08/22/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND Securinine is an alkaloid identified from the roots and leaves of the shrub Flueggea suffruticosa (Pall.) Baill. The molecular structure of securinine consists of four rings, including three chiral centers. It has been suggested that securinine can be chemically synthesized from tyrosine and lysine. Securinine has long been used to treat central nervous system diseases. In recent years, more and more evidence shows that securinine also has anticancer activity, which has not been systematically discussed and analyzed. PURPOSE This study aims to propose an overall framework to describe the molecular targets of securinine in different signal pathways, and discuss the current status and prospects of each pathway, so as to provide a theoretical basis for the development securinine as an effective anticancer drug. METHODS The research databases on the anticancer activity of securinine from PubMed, Scopus, Web of Science and ScienceDirect to 2021 were systematically searched. This paper follows the Preferred Reporting Items and Meta-Analysis guidelines. RESULTS Securinine has the ability to kill a variety of human cancer cells, including, leukemia as well as prostate, cervical, breast, lung, and colon cancer cells. It can regulate the signal pathways of phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin, Wnt and Janus kinase-signal transducer and activator of transcription, promote cancer cell apoptosis and autophagy, and inhibit cancer cell metastasis. Securinine also has the activity of inducing leukemia cell differentiation. CONCLUSION Although there has been some experimental evidence indicating the anticancer effect of securinine and its possible pharmacology, in order to design more effective anticancer drugs, it is necessary to study the synergy of intracellular signaling pathways. More in vivo experiments and even clinical studies are needed, and the synergy between securinine and other drugs is also worth studying.
Collapse
Affiliation(s)
- Chang-Jun Liu
- College of Food and Bioengineering, South China University of Technology, Guangzhou 510640, China
| | - Xiao-Dan Fan
- College of Food and Bioengineering, South China University of Technology, Guangzhou 510640, China
| | - Jian-Guo Jiang
- College of Food and Bioengineering, South China University of Technology, Guangzhou 510640, China.
| | - Qiu-Xiong Chen
- The second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510120, China
| | - Wei Zhu
- The second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
| |
Collapse
|
4
|
Le Roch M, Afonso D, Chirkin E, Guillory X, Porée FH. Structure simplification of the Securinine skeleton reveals the importance of BCD ring system for the cytotoxic activity on HCT116 and HL60 cell lines. Bioorg Med Chem 2022; 58:116658. [DOI: 10.1016/j.bmc.2022.116658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Revised: 01/24/2022] [Accepted: 02/08/2022] [Indexed: 11/24/2022]
|
5
|
Ashraf SM, Mahanty S, Rathinasamy K. Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: A possible mechanistic basis for its anticancer activity. Life Sci 2021; 287:120105. [PMID: 34756929 DOI: 10.1016/j.lfs.2021.120105] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 10/20/2021] [Accepted: 10/25/2021] [Indexed: 10/20/2022]
Abstract
AIM Analysis of the anticancer and antimitotic activity of the plant derived alkaloid securinine along with its effect on the organization of cellular microtubules as well as its binding with purified goat brain tubulin in-vitro. MATERIALS AND METHODS The cytotoxicity of securinine on different cell lines was conducted using SRB assay. The effect of securinine on the cellular microtubules was analyzed using immunofluorescence microscopy. The binding of securinine on purified goat brain tubulin was evaluated using fluorescent spectroscopy. KEY FINDINGS Securinine effectively prevented the proliferation of cervical, breast and lung cancer cells with an IC50 of 6, 10 and 11 μM respectively and induced minimal toxicity in HEK cell line. Securinine at concentrations higher than IC50 induced significant depolymerization in interphase and mitotic microtubules and it suppressed the reassembly of cold depolymerized spindle microtubules in HeLa cells. In the wound healing assay, securinine effectively suppressed the migration of HeLa cells to close the wound. Securinine bound to tubulin with a Kd of 9.7 μM and inhibited the assembly of tubulin into microtubules. The treatment with securinine induced a mitochondrial dependent ROS response in HeLa cells which enhanced the cytotoxic effect of securinine. The result from gene expression studies indicates that securinine induced apoptosis in MCF-7 cells through p53 dependent pathway. SIGNIFICANCE Considering the strong anticancer and anti-metastatic property and low toxicity in non-malignant cell lines, we suggest that securinine can be used as a chemotherapeutic drug either alone or in combination with other known anticancer molecules.
Collapse
Affiliation(s)
- Shabeeba M Ashraf
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India
| | - Susobhan Mahanty
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India
| | - Krishnan Rathinasamy
- School of Biotechnology, National Institute of Technology Calicut, Calicut, Kerala, India.
| |
Collapse
|
6
|
Yu L, Xu F, Gao L. Predict New Therapeutic Drugs for Hepatocellular Carcinoma Based on Gene Mutation and Expression. Front Bioeng Biotechnol 2020; 8:8. [PMID: 32047745 PMCID: PMC6997129 DOI: 10.3389/fbioe.2020.00008] [Citation(s) in RCA: 39] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Accepted: 01/07/2020] [Indexed: 02/01/2023] Open
Abstract
Hepatocellular carcinoma (HCC) is the fourth most common primary liver tumor and is an important medical problem worldwide. However, the use of current therapies for HCC is no possible to be cured, and despite numerous attempts and clinical trials, there are not so many approved targeted treatments for HCC. So, it is necessary to identify additional treatment strategies to prevent the growth of HCC tumors. We are looking for a systematic drug repositioning bioinformatics method to identify new drug candidates for the treatment of HCC, which considers not only aberrant genomic information, but also the changes of transcriptional landscapes. First, we screen the collection of HCC feature genes, i.e., kernel genes, which frequently mutated in most samples of HCC based on human mutation data. Then, the gene expression data of HCC in TCGA are combined to classify the kernel genes of HCC. Finally, the therapeutic score (TS) of each drug is calculated based on the kolmogorov-smirnov statistical method. Using this strategy, we identify five drugs that associated with HCC, including three drugs that could treat HCC and two drugs that might have side-effect on HCC. In addition, we also make Connectivity Map (CMap) profiles similarity analysis and KEGG enrichment analysis on drug targets. All these findings suggest that our approach is effective for accurate predicting novel therapeutic options for HCC and easily to be extended to other tumors.
Collapse
Affiliation(s)
- Liang Yu
- School of Computer Science and Technology, Xidian University, Xi'an, China
| | - Fengdan Xu
- School of Computer Science and Technology, Xidian University, Xi'an, China
| | - Lin Gao
- School of Computer Science and Technology, Xidian University, Xi'an, China
| |
Collapse
|
7
|
Antien K, Lacambra A, Cossío FP, Massip S, Deffieux D, Pouységu L, Peixoto PA, Quideau S. Bio‐inspired Total Synthesis of Twelve
Securinega
Alkaloids: Structural Reassignments of (+)‐Virosine B and (−)‐Episecurinol A. Chemistry 2019; 25:11574-11580. [DOI: 10.1002/chem.201903122] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2019] [Revised: 07/19/2019] [Indexed: 11/08/2022]
Affiliation(s)
- Kevin Antien
- Univ. Bordeaux, ISM (CNRS-UMR 5255) 351 cours de la Libération 33405 Talence Cedex France
| | - Aitor Lacambra
- Univ. Bordeaux, ISM (CNRS-UMR 5255) 351 cours de la Libération 33405 Talence Cedex France
- Departamento de Química Orgánica IUniversidad del País Vasco Avda. Tolosa 72, Edificio Korta 20018 San Sebastián Spain
| | - Fernando P. Cossío
- Departamento de Química Orgánica IUniversidad del País Vasco Avda. Tolosa 72, Edificio Korta 20018 San Sebastián Spain
| | - Stéphane Massip
- Univ. BordeauxInstitut Européen de Chimie et Biologie (CNRS-UMS 3033) 2 rue Robert Escarpit 33607 Pessac Cedex France
| | - Denis Deffieux
- Univ. Bordeaux, ISM (CNRS-UMR 5255) 351 cours de la Libération 33405 Talence Cedex France
| | - Laurent Pouységu
- Univ. Bordeaux, ISM (CNRS-UMR 5255) 351 cours de la Libération 33405 Talence Cedex France
| | - Philippe A. Peixoto
- Univ. Bordeaux, ISM (CNRS-UMR 5255) 351 cours de la Libération 33405 Talence Cedex France
| | - Stéphane Quideau
- Univ. Bordeaux, ISM (CNRS-UMR 5255) 351 cours de la Libération 33405 Talence Cedex France
| |
Collapse
|
8
|
Tang G, Liu X, Ma N, Huang X, Wu ZL, Zhang W, Wang Y, Zhao BX, Wang ZY, Ip FCF, Ip NY, Ye WC, Shi L, Chen WM. Design and Synthesis of Dimeric Securinine Analogues with Neuritogenic Activities. ACS Chem Neurosci 2016; 7:1442-1451. [PMID: 27467236 DOI: 10.1021/acschemneuro.6b00188] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Neurite outgrowth is crucial during neuronal development and regeneration, and strategies that aim at promoting neuritogenesis are beneficial for reconstructing synaptic connections after neuronal degeneration and injury. Using a bivalent analogue strategy as a successful approach, the current study identifies a series of novel dimeric securinine analogues as potent neurite outgrowth enhancers. Compounds 13, 14, 17-19, and 21-23, with different lengths of carbon chain of N,N-dialkyl substituting diacid amide linker between two securinine molecules at C-15 position, exhibited notable positive effects on both neuronal differentiation and neurite extension of neuronal cells. Compound 14, one of the most active compounds, was used as a representative compound for mechanistic studies. Its action on neurite outgrowth was through phosphorylation/activation of multiple signaling molecules including Ca2+/calmodulin-dependent protein kinase II (CaMKII), extracellular signal-regulated kinase (ERK) and Akt. These findings collectively identify a new group of beneficial compounds for neuritogenesis, and may provide insights on drug discovery of neural repair and regeneration.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Fanny C. F. Ip
- Division
of Life Science, State Key Laboratory of Molecular Neuroscience and
Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon,
Hong Kong, China
| | - Nancy Y. Ip
- Division
of Life Science, State Key Laboratory of Molecular Neuroscience and
Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon,
Hong Kong, China
| | | | | | | |
Collapse
|
9
|
Cornil J, Echeverria PG, Reymond S, Phansavath P, Ratovelomanana-Vidal V, Guérinot A, Cossy J. Synthetic Studies toward the C14–C29 Fragment of Mirabalin. Org Lett 2016; 18:4534-7. [DOI: 10.1021/acs.orglett.6b02162] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Johan Cornil
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI)-UMR 8231, ESPCI Paris/CNRS/PSL Research University, 10 rue Vauquelin 75231 Cedex 05 Paris, France
| | - Pierre-Georges Echeverria
- PSL Research University, Chimie ParisTech - CNRS, Institut de Recherche de Chimie Paris, 75005 Paris, France
| | - Sébastien Reymond
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI)-UMR 8231, ESPCI Paris/CNRS/PSL Research University, 10 rue Vauquelin 75231 Cedex 05 Paris, France
| | - Phannarath Phansavath
- PSL Research University, Chimie ParisTech - CNRS, Institut de Recherche de Chimie Paris, 75005 Paris, France
| | | | - Amandine Guérinot
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI)-UMR 8231, ESPCI Paris/CNRS/PSL Research University, 10 rue Vauquelin 75231 Cedex 05 Paris, France
| | - Janine Cossy
- Laboratoire
de Chimie Organique, Institute of Chemistry, Biology and Innovation
(CBI)-UMR 8231, ESPCI Paris/CNRS/PSL Research University, 10 rue Vauquelin 75231 Cedex 05 Paris, France
| |
Collapse
|
10
|
Perez M, Ayad T, Maillos P, Poughon V, Fahy J, Ratovelomanana-Vidal V. Synthesis and Antiproliferative and Metabolic Evaluations of Novel Securinine Derivatives. ACS Med Chem Lett 2016; 7:403-7. [PMID: 27096049 DOI: 10.1021/acsmedchemlett.5b00441] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2015] [Accepted: 02/02/2016] [Indexed: 11/30/2022] Open
Abstract
New securinine analogues have been prepared by semisynthesis. Two series were developed using either Suzuki or Sonogashira cross coupling reactions. The in vitro cytotoxicity of the compounds was assayed against HCT-116 colon cancer cells. The most potent derivatives showed promising growth inhibition on four tumoral cell lines giving a valuable insight on the structure-activity relationship (SAR) of securinine. Moreover, high antiproliferative effect against A-375 (melanoma) was observed with IC50 up to 60 nM.
Collapse
Affiliation(s)
- Marc Perez
- PSL Research University, Chimie ParisTech - CNRS, Institut de Recherche de Chimie Paris, 75005 Paris, France
| | - Tahar Ayad
- PSL Research University, Chimie ParisTech - CNRS, Institut de Recherche de Chimie Paris, 75005 Paris, France
| | | | - Valérie Poughon
- Unité de Service et de Recherche CNRS-Pierre Fabre n°3388 ETaC CRDPF, 31035 Toulouse, France
| | - Jacques Fahy
- Unité de Service et de Recherche CNRS-Pierre Fabre n°3388 ETaC CRDPF, 31035 Toulouse, France
| | | |
Collapse
|